Helicobacter Pylori eradication therapy: getting research into practice.
AffiliationEastern Regional Health Authority, Health Information Unit, Department of Public Health, Dr Steeven's Hospital, Dublin 8, Ireland. firstname.lastname@example.org
Local subject classificationULCER, DUODENAL
Education, Medical, Continuing
Practice Guidelines as Topic
MetadataShow full item record
CitationMcDonnell R et al. Helicobacter Pylori eradication therapy: getting research into practice. Ir Med J. 2003;96(1):13-6
JournalIrish medical journal
AbstractHelicobacter Pylori (H. Pylori) is the primary cause of duodenal ulcer (DU). Guidelines recommend that all patients with DU be considered for Helicobacter Pylori Eradication Therapy (HPET). However, the proportion of patients with DU on long term anti-ulcer medication receiving HPET is small. This study examined the effectiveness of the continuing medical education (CME) network of the Irish College of General Practitioners (ICGP) in promoting best practice in DU treatment among GPs in an eastern region of Ireland. Ninty eight GPs recruited from the CME network of the ICGP were randomised in two cohorts. Cohort 1 received an (early) intervention; GPs were asked to identify their patients with DU receiving long term anti-ulcer medication and prescribe HPET according to defined criteria. Cohort 2 received the intervention later. Prescribing of HPET was monitored using routine prescribing data. Twenty per cent (286/1,422) of patients in cohort 1 and 19.2% (127/661) in cohort 2 had a DU. After exclusions, 53% (152/286) in cohort 1 and 30.7% (39/127) in cohort 2, were eligible for HPET. A significantly higher proportion of patients in cohort 1 received HPET compared with cohort 2 during the early intervention period (13.8% vs 0.0%, p<0.05). Reasons for not prescribing HPET included concurrent illness in patients, failure to comply with treatment. Best practice guidelines on HPET treatment of DU can be successfully applied using CME networks. This model could be repeated in another therapeutic area where established research is not yet current practice.
- Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
- Authors: Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D
- Issue date: 2007 Dec
- Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer.
- Authors: Chang FY, Lu CL, Chen CY, Luo JC, Jium KL, Lee SD
- Issue date: 2003 Nov
- Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?
- Authors: Unge P, Kimura K, Sipponen P, Ekström P, Satoh K, Hellblom M, Ohlin B, Stubberöd A, Kihira K, Yube T, Yoshida Y
- Issue date: 2003 May
- The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis.
- Authors: Lo GH, Yu HC, Chan YC, Chen WC, Hsu PI, Lin CK, Lai KH
- Issue date: 2005 Sep
- Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
- Authors: Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD
- Issue date: 2008 Jul